IOBTIO Biotech, Inc.

$21M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$230,000

Operating Income

-$19M

Net Income

-$8M

EPS (Diluted)

$-0.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$40M

Total Liabilities

$39M

Stockholders' Equity

$911,000

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$230,000	-$205,000	-12.2%
Operating Income	-$19M	-$27M	+27.0%
Net Income	-$8M	-$24M	+65.1%

IOBT Q3 2025 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena